Generate-Boost: study protocol for a prospective, multicenter, randomized controlled, double-blinded phase II trial to evaluate efficacy and safety of bortezomib in patients with severe autoimmune encephalitis

Peer Review reports

Original Submission
30 Mar 2020	Submitted	Original manuscript
30 May 2020	Reviewed	Reviewer Report - Riaz Qureshi
9 Jun 2020	Author responded	Author comments - Jonathan Wickel
Resubmission - Version 2
9 Jun 2020	Submitted	Manuscript version 2
12 Jun 2020	Reviewed	Reviewer Report - Riaz Qureshi
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
15 Jun 2020	Editorially accepted
8 Jul 2020	Article published	10.1186/s13063-020-04516-7

Back to article page